SG11202012343TA - Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration - Google Patents
Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegenerationInfo
- Publication number
- SG11202012343TA SG11202012343TA SG11202012343TA SG11202012343TA SG11202012343TA SG 11202012343T A SG11202012343T A SG 11202012343TA SG 11202012343T A SG11202012343T A SG 11202012343TA SG 11202012343T A SG11202012343T A SG 11202012343TA SG 11202012343T A SG11202012343T A SG 11202012343TA
- Authority
- SG
- Singapore
- Prior art keywords
- onset
- progression
- age
- compositions
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862684496P | 2018-06-13 | 2018-06-13 | |
PCT/US2019/036946 WO2019241503A1 (en) | 2018-06-13 | 2019-06-13 | Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202012343TA true SG11202012343TA (en) | 2021-01-28 |
Family
ID=68838925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202012343TA SG11202012343TA (en) | 2018-06-13 | 2019-06-13 | Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration |
Country Status (11)
Country | Link |
---|---|
US (2) | US20210252023A1 (de) |
EP (1) | EP3806862A4 (de) |
JP (1) | JP2021527090A (de) |
KR (1) | KR20210009422A (de) |
CN (1) | CN112566641A (de) |
AU (1) | AU2019285065A1 (de) |
BR (1) | BR112020025296A2 (de) |
CA (1) | CA3103463A1 (de) |
MX (1) | MX2020013614A (de) |
SG (1) | SG11202012343TA (de) |
WO (1) | WO2019241503A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11464789B2 (en) | 2018-08-03 | 2022-10-11 | Enterin, Inc. | Aminosterol compositions and methods of using the same for treating schizophrenia |
US20210260078A1 (en) * | 2018-08-03 | 2021-08-26 | Philadelphia | Low dosage intranasal aminosterol dosage forms and methods of using the same |
EP3829587A4 (de) * | 2018-08-03 | 2022-07-20 | Enterin, Inc. | Zusammensetzungen und verfahren zur behandlung von hirn-darm-störungen |
CN110827282B (zh) * | 2020-01-13 | 2020-04-10 | 南京慧脑云计算有限公司 | 一种基于磁共振成像的脑白质纤维束示踪分析方法及系统 |
CN111110873A (zh) * | 2020-02-24 | 2020-05-08 | 苏州欣影生物医药技术有限公司 | 一种磁共振/核医学双模态分子影像探针的制备方法 |
CN111528839B (zh) * | 2020-05-29 | 2023-06-23 | 北京京东方健康科技有限公司 | 睡眠检测方法和装置、助眠设备和方法 |
JP2024519927A (ja) * | 2021-05-21 | 2024-05-21 | アニマスキュア インコーポレイテッド. | イノトジオールを含む筋疾患の予防または治療用組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6143738A (en) * | 1995-06-07 | 2000-11-07 | Magainin Pharmaceuticals, Inc. | Therapeutic uses for an aminosterol compound |
CA2922021C (en) * | 2007-09-06 | 2018-01-09 | Ohr Pharmaceutical, Inc. | A method for treating diabetes |
US8623416B2 (en) * | 2009-11-25 | 2014-01-07 | Michael Zasloff | Formulations comprising aminosterols |
US10040817B2 (en) * | 2013-10-03 | 2018-08-07 | Enterin Laboratories, Inc. | Methods and compositions for stimulation of the intestinal enteroendocrine system for treating diseases or conditions related to the same |
-
2019
- 2019-06-13 AU AU2019285065A patent/AU2019285065A1/en active Pending
- 2019-06-13 MX MX2020013614A patent/MX2020013614A/es unknown
- 2019-06-13 JP JP2020569002A patent/JP2021527090A/ja active Pending
- 2019-06-13 KR KR1020217000559A patent/KR20210009422A/ko not_active Application Discontinuation
- 2019-06-13 BR BR112020025296-4A patent/BR112020025296A2/pt unknown
- 2019-06-13 US US17/251,322 patent/US20210252023A1/en active Pending
- 2019-06-13 US US16/440,414 patent/US20190381071A1/en not_active Abandoned
- 2019-06-13 WO PCT/US2019/036946 patent/WO2019241503A1/en unknown
- 2019-06-13 CN CN201980052151.2A patent/CN112566641A/zh active Pending
- 2019-06-13 CA CA3103463A patent/CA3103463A1/en active Pending
- 2019-06-13 SG SG11202012343TA patent/SG11202012343TA/en unknown
- 2019-06-13 EP EP19818961.5A patent/EP3806862A4/de active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3806862A1 (de) | 2021-04-21 |
CA3103463A1 (en) | 2019-12-19 |
AU2019285065A1 (en) | 2021-01-07 |
KR20210009422A (ko) | 2021-01-26 |
US20190381071A1 (en) | 2019-12-19 |
US20210252023A1 (en) | 2021-08-19 |
CN112566641A (zh) | 2021-03-26 |
BR112020025296A2 (pt) | 2021-03-09 |
MX2020013614A (es) | 2021-05-27 |
WO2019241503A1 (en) | 2019-12-19 |
EP3806862A4 (de) | 2022-07-06 |
JP2021527090A (ja) | 2021-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202006627B (en) | Methods and compositions for treating cancer | |
SG11202012343TA (en) | Methods and compositions for treating and/or preventing the progression and/or onset of age-related neurodegeneration | |
EP3894392A4 (de) | Zusammensetzungen und verfahren zur behandlung von krebs | |
IL273959A (en) | Methods and preparations for the treatment of rare diseases | |
IL276808A (en) | Preparations and methods for the treatment of cancer | |
GB2578539B (en) | Compositions and methods for preventing or treating muscle conditions | |
IL275626A (en) | Preparations and methods for surface treatment | |
SG11202012055PA (en) | Methods and compositions for preventing or treating calciphylaxis | |
SG11202012070YA (en) | Methods and compositions for preventing or treating tissue calcification | |
IL280413A (en) | Bismuth-thiol preparations and wound treatment methods | |
SG11202103033WA (en) | Compositions and methods for the treatment of presbyopia | |
IL285886A (en) | Preparations and methods for the treatment of laminopathy | |
IL287796A (en) | Preparations and methods for the treatment of diseases mediated by ATPase | |
SG11202012435UA (en) | Compositions and methods for treating cancer | |
IL276203A (en) | Compounds and methods for treating cancer | |
SG11202102442WA (en) | Methods and compositions for preventing and treating atherosclerosis and related diseases | |
IL285796A (en) | Methods and preparations for the treatment of cancer | |
GB202001422D0 (en) | Compositions and methods for preventing or treating nephrolithiasis | |
IL280218A (en) | Methods for the treatment of HFPEF using dapagliflozin and compounds containing it | |
IL280348A (en) | Surface treatment compositions and methods | |
PL3810128T3 (pl) | Kompozycje do leczenia i/lub zapobiegania chorobom związanym z agregacją białek | |
IL272147A (en) | Methods and preparations for the treatment of cancer | |
IL280262A (en) | Compositions and methods for treating cancer | |
EP3987032A4 (de) | Verfahren und zusammensetzungen zur krebsbehandlung | |
IL282948A (en) | Preparations and methods for the treatment of cancer |